Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared

Similar Items

• Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
  by: S. O. Kochkina, et al.
  Published: (2020-08-01)
• Estimating the mesorectal fascia in MRI.
  by: Bond, S, et al.
  Published: (2007)
• Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
  by: Junichi Nishimura, et al.
  Published: (2020-07-01)
• Adding Three Cycles of CAPOX after Neoadjuvant Chemoradiotherapy Increases the Rates of Complete Response for Locally Advanced Rectal Cancer
  by: Zhiwei Zhai, et al.
  Published: (2021-01-01)
• Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
  by: Fang He, et al.
  Published: (2022-10-01)